Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States)
- 1 November 1996
- journal article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 7 (6) , 575-580
- https://doi.org/10.1007/bf00051699
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dose-Response and Trend Analysis in EpidemiologyEpidemiology, 1995
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Postmenopausal unopposed estrogens characteristics of use in relation to the risk of endometrial carcinomaAnnals of Epidemiology, 1993
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Progestagen supplementation of exogenous oestrogens and risk of endometrial cancerThe Lancet, 1991
- Survival in women receiving hormone replacement therapy.: A record-linkage study of a large population-based cohortJournal of Clinical Epidemiology, 1990
- Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversiesAmerican Journal of Obstetrics and Gynecology, 1990
- Climacteric Symptoms and Estrogen Replacement Therapy In Women with Endometrial CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1986
- Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated EstrogensNew England Journal of Medicine, 1985
- Sampling Methods for Random Digit DialingJournal of the American Statistical Association, 1978